
cyclosporine opht brand names and other generic formulations include:
riociguat oral brand names and other generic formulations include:
Adempas Oral
cyclosporine opht and riociguat oral
cyclosporine opht will increase the level or effect of riociguat oral by affects how the drug is eliminated from the body (via what is known as the P-glycoprotein [MDR1] transporter). Combination may increase blood levels of riociguat, requiring a reduced dose of riociguat. Your doctor will monitor for low blood pressure (hypotension).
cyclosporine opht and riociguat oral
cyclosporine opht will increase the level or effect of riociguat oral by P-glycoprotein (MDR1) efflux transporter. Coadministration of riociguat (P-gp substrate) with strong P-gp inhibitors may require a decreased initial dose of 0.5 mg PO TID; monitor for signs of hypotension and reduce dose if needed
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant